
### [NCIT:C27912](http://purl.obolibrary.org/obo/NCIT_C27912)
**Label:** Therapy-Related Myeloid Neoplasm

**Subclasses:** [NCIT:C82397](http://purl.obolibrary.org/obo/NCIT_C82397) (Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm), [NCIT:C7643](http://purl.obolibrary.org/obo/NCIT_C7643) (Alkylating Agent-Related Myelodysplastic Syndrome), [NCIT:C27913](http://purl.obolibrary.org/obo/NCIT_C27913) (Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome), [NCIT:C7642](http://purl.obolibrary.org/obo/NCIT_C7642) (Epipodophyllotoxin-Related Myelodysplastic Syndrome), [NCIT:C27755](http://purl.obolibrary.org/obo/NCIT_C27755) (Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia), [NCIT:C27722](http://purl.obolibrary.org/obo/NCIT_C27722) (Therapy-Related Myelodysplastic Syndrome), [NCIT:C27754](http://purl.obolibrary.org/obo/NCIT_C27754) (Alkylating Agent-Related Acute Myeloid Leukemia), [NCIT:C8252](http://purl.obolibrary.org/obo/NCIT_C8252) (Therapy-Related Acute Myeloid Leukemia), 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40301](http://purl.obolibrary.org/obo/NCIT_C40301) (Adenoma of Minor Vestibular Glands))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40299](http://purl.obolibrary.org/obo/NCIT_C40299) (Bartholin Gland Adenoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40298](http://purl.obolibrary.org/obo/NCIT_C40298) (Bartholin Gland Small Cell Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40297](http://purl.obolibrary.org/obo/NCIT_C40297) (Bartholin Gland Transitional Cell Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40296](http://purl.obolibrary.org/obo/NCIT_C40296) (Bartholin Gland Adenosquamous Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40295](http://purl.obolibrary.org/obo/NCIT_C40295) (Bartholin Gland Adenoid Cystic Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40293](http://purl.obolibrary.org/obo/NCIT_C40293) (Bartholin Gland Squamous Cell Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40290](http://purl.obolibrary.org/obo/NCIT_C40290) (Vestibular Micropapillomatosis))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40287](http://purl.obolibrary.org/obo/NCIT_C40287) (Vulvar Warty Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40286](http://purl.obolibrary.org/obo/NCIT_C40286) (Vulvar Basaloid Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40284](http://purl.obolibrary.org/obo/NCIT_C40284) (Vulvar Keratinizing Squamous Cell Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40275](http://purl.obolibrary.org/obo/NCIT_C40275) (Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40272](http://purl.obolibrary.org/obo/NCIT_C40272) (Vaginal Undifferentiated Sarcoma))) 40.36%


